trending Market Intelligence /marketintelligence/en/news-insights/trending/pgjycxqkhfoarzmd-0z9mw2 content esgSubNav
In This List

Seattle Genetics appoints board member

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Seattle Genetics appoints board member

Seattle Genetics Inc. added Alpna Seth to its board.

Seth is the COO of Vir Biotechnology, a San Francisco-based company focused on developing treatments for viral and bacterial diseases.

Prior to joining Vir Biotechnology, she was a senior vice president and the global head of Biogen Inc.'s biosimilars business.